Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Avera McKennan Hospital & University Health Center
Subjects will be randomized to one of two groups: one group will take 500 mg of the investigational product (IHBG-10) 15 minutes prior to the three main meals of the day; the other group will take placebo 15 minutes prior to the three main meals of the day. Subjects will be on the investigational product or placebo for 12 weeks. Participation in this study involves four study visits.
Age
18–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Age 18 and older
Body mass index of 30 or greater
Agree to keep diet, exercise and all current health habits stable during participation in the study
You may not be if
Women who are pregnant, breastfeeding or planning to become pregnant
Prior bariatric surgery
Use of prescription or over-the-counter appetite suppressants, herbal products or other medications for weight loss within the past month
Obesity as a result of a clinically diagnosed endocrine problem
Currently taking an anti-psychotic medication
History of peptic ulcer disease
Clareo Health | Randomized Study to Evaluate the Effect of an Investigational Product on Weight Loss and Body Composition
